Imaging agents for detecting neurological dysfunction

US8932557B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8932557-B2
Application numberUS-201213477095-A
CountryUS
Kind codeB2
Filing dateMay 22, 2012
Priority dateFeb 14, 2008
Publication dateJan 13, 2015
Grant dateJan 13, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled carbazoles and derivatives thereof and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease.

First claim

Opening claim text (preview).

We claim: 1. A compound that is: or pharmaceutically acceptable salts thereof, wherein R 21 is selected from the group consisting of F, Cl, Br, I, 18 F, 77 Br, 123 I, 124 I, 125 I, 131 I, and NO 2 . 2. A compound which is: 7-(6-Nitropyridine-3-yl)-5H-pyrido[4,3-b]indole; or pharmaceutically acceptable salts thereof. 3. A compound that is 7-[6-( 18 F)fluoropyridin-3-yl]-5H-pyrido[4,3-b]indole: or a pharmaceutically acceptable salt thereof. 4. A compound that is 7-[6-fluoropyridin-3-yl]-5H-pyrido[4,3-b]indole: or a pharmaceutically acceptable salt thereof. 5. A process for the preparation of 7-[6-( 18 F)fluoropyridin-3-yl]-5H-pyrido[4,3-b]indole, comprising reacting 7-(6-nitropyridine-3-yl)-5H-pyrido[4,3-b]indole with anhydrous [F-18]fluoride ion.

Assignees

Inventors

Classifications

  • Ortho-condensed systems · CPC title

  • C07B59/002Primary

    Heterocyclic compounds · CPC title

  • Ortho-condensed systems · CPC title

  • having six-membered rings with one nitrogen as the only ring hetero atom · CPC title

  • having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8932557B2 cover?
Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled carbazoles and derivatives thereof and triazoles derivatives, allowing the compound to dist…
Who is the assignee on this patent?
Chen Gang, Gangadharmath Umesh B, Kasi Dhanalakshmi, and 5 more
What technology area does this patent fall under?
Primary CPC classification C07B59/002. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).